L-carnitine Supplementation in Rheumatoid Arthritis Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Rheumatoid Arthritis (RA)
Interventions
DRUG

Carnitine

"It is a nutritional supplement with trade name Carnitol® in Egypt."

DRUG

Disease-modifying anti-rheumatic drugs

They are immunosuppressive drugs used to improve disease activity in Rheumatoid Arthritis patients . Conventional DMARDs include methotrexate (Imutrexate®) , leflunomide(Arthfree®) , hydroxychloroquine (plaquenil®) and sulfasalazine(colosalazine®) .

Trial Locations (1)

Unknown

RECRUITING

Demerdash hospital, Cairo

All Listed Sponsors
lead

German University in Cairo

OTHER